Skip to content
Signal Bureau What’s happening · what the record shows

Colorectal Cancer

Cancer of the colon or rectum — among the most common cancers worldwide and a major focus of screening and drug development.

Coverage of Colorectal Cancer is fading : 58 signals on the latest tracked day, down 61% from its three-week baseline of 147, across 3 domains (down from 4 a week ago). That makes it the #33 most-covered of the 348 concerns we track.

If Colorectal Cancer matters to your work, attention is draining away — the pace of news no longer demands a daily check.

What’s changed

6 of the last 7 tracked days ran below the three-week baseline — a sustained cooling, not a one-day dip.

What the reporting says

It shows up alongside Immunotherapy (208), KRAS (109), ctDNA (107), Braf (75), MSI-H (57), Egfr (50), Systematic Review (46), Wang (59).

Two steps out: Lung Cancer (through KRAS, 66 shared stories on the weaker link); G12d (through KRAS, 60 shared stories on the weaker link); Pancreatic Cancer (through KRAS, 49 shared stories on the weaker link); KRAS Mutant (through KRAS, 46 shared stories on the weaker link).

Tracked since Jul 21, with coverage on 178 separate days — concentrated in Pubmed Targeted and Oncology.

Ask the engine about Colorectal Cancer + Track Colorectal Cancer for a daily read
Counts computed from our committed signal record (Jul 28 – Sep 4, 18 tracked days). Informational only — not financial, legal, or investment advice. Prediction-market prices are shown as a signal of what the crowd believes. Terms · Privacy · page rendered Sep 4, 8:22 PM PT